| Mon, Nov 9, 2009 | | • | MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon 5:16pm)
| | Mon, Nov 2, 2009 | | • | Medicines Co. Misses & Cuts
Zacks.com (Mon, Nov 2)
| | Wed, Oct 28, 2009 | | • | MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Oct 28)
| | • | The Medicines Company Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Oct 28)
| | • | The Medicines Company Reports Third Quarter 2009 Financial Results
Marketwire (Wed, Oct 28)
| | • | Q3 2009 The Medicines Company Earnings Release - Before Market Open
CCBN (Wed, Oct 28)
| | Fri, Oct 23, 2009 | | • | Medicines Co. gets positive EU panel result
AP (Fri, Oct 23)
| | • | The Medicines Company Announces Positive CHMP Opinion for Angiox® (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Business Wire (Fri, Oct 23)
| | Thu, Oct 15, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Thu, Oct 15)
| | Thu, Oct 8, 2009 | | • | Medicines Co. sues generic rivals over Angiomax
AP (Thu, Oct 8)
| | • | The Medicines Company Files Patent Infringement Lawsuits
Marketwire (Thu, Oct 8)
| | • | The Medicines Company Announces Second New Patent Issuance for Angiomax(R)
Marketwire (Thu, Oct 8)
| | Tue, Oct 6, 2009 | | • | MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Tue, Oct 6)
| | • | Medicines sets 3Q revenue outlook below forecasts
AP (Tue, Oct 6)
| | • | The Medicines Company Announces Preliminary Third Quarter 2009 Top Line Results
Marketwire (Tue, Oct 6)
| | Mon, Oct 5, 2009 | | • | MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Oct 5)
| | Fri, Oct 2, 2009 | | • | Medicines Co. President, COO John Kelley resigns
AP (Fri, Oct 2)
| | • | The Medicines Company Announces the Resignation of Its Chief Operating Officer
Marketwire (Fri, Oct 2)
| | Wed, Sep 30, 2009 | | • | The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Wed, Sep 30)
| | Tue, Sep 29, 2009 | | • | The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise and Potential Near Term Revenue Opportunity
Marketwire (Tue, Sep 29)
|
Add MDCO News to My Yahoo!:
 
| |
|
0.09% Nasdaq 
Headlines
